Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.64
-0.17 (-4.46%)
At close: Aug 14, 2025, 3:59 PM
3.67
0.82%
Pre-market: Aug 15, 2025, 09:18 AM EDT

Prime Medicine Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
182.48M 41.57M 187.62M 185.42M
Short-Term Investments
7.97M 80.09M 106.3M 84.2M
Long-Term Investments
n/a n/a 13.5M 13.13M
Other Long-Term Assets
14.06M 14.28M -52.76M 2.47M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
14.67M 2.25M 246K 959K
Total Current Assets
211.89M 142.98M 293.92M 270.58M
Property-Plant & Equipment
71.56M 36.6M 48.55M 15.68M
Goodwill & Intangibles
n/a n/a -13.5M n/a
Total Long-Term Assets
85.62M 50.88M 66.39M 31.28M
Total Assets
297.51M 193.85M 360.31M 301.86M
Account Payables
11.35M 19.54M 4.33M 1.44M
Deferred Revenue
7.09M n/a n/a 36.91M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
6.93M 19.34M 4.16M 14.66M
Total Current Liabilities
37.96M 56.42M 26.71M 57.98M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
43.18M n/a n/a n/a
Total Long-Term Liabilities
106.4M 4.36M 17.33M 4.31M
Total Liabilities
144.36M 60.78M 360.31M 62.3M
Total Debt
40.79M 13.63M 28.75M 10.41M
Common Stock
2K 2K 2K 1K
Retained Earnings
-687.21M -491.33M -293.2M -171.38M
Comprehensive Income
1K -15K -384K -27K
Shareholders Equity
153.15M 133.07M -293.58M 239.56M
Total Investments
7.97M 80.09M 106.3M 84.2M